United States

Vernalis PLC Announces CTI Becomes Worldwide Licensee for Tosedostat

Vernalis plc today announces that CTI BioPharma Corp. (CTI), a US corporation publicly listed on NASDAQ, replaces the UK venture capital backed Chroma Therapeutics (Chroma) as worldwide licensee of tosedostat. CTI previously held rights to tosedostat in the Americas under a Licence Agreement with Chroma. Chroma no longer retains any ongoing rights or financial interest in tosedostat.


'Ouija' spells out win on U.S., Canada movie charts

"Ouija", a horror film inspired by the board said to contact the dead, haunted the top of movie charts in the United States and Canada, collecting $20 million in weekend ticket sales and knocking Brad Pitt's "Fury" out of first place.

Energy stocks attractive after steep sell-off: Barron's

A steep sell-off in energy company stocks in recent months due to falling oil prices may be overdone and there are some potential bargains to be had, Barron's financial newspaper said in its latest edition on Sunday.

Federal Reserve to take away the punch bowl

Unless it springs a major surprise, the U.S. Federal Reserve will call time this week on its program of government bond purchases, which at one point was pumping $85 billion a month into financial markets and the economy.


Latest News

More than a dozen oil producers have joined to lobby the federal government to reverse the 40-year-old ban on U.S. crude exports, a move that supporters say would create jobs and keep the energy boom alive, a spokesman for one of the companies and a lobbyist for another one said on Friday.
Lantern, a technology startup that offers online and mobile coaching programs to support mental health, has won early backing for its service.
U.S. TV startup Roku Inc is working on plans to confidentially file for an initial public offering, the Wall Street Journal reported, citing people familiar with the matter.
Hewlett-Packard Co (HPQ.N) has begun sounding out private-equity firms in China to buy its corporate-networking business in the country, the Wall Street Journal reported, citing people familiar with the situation.
Amgen Inc (AMGN.O), one of the world's largest biotechnology companies, will unveil next week its first strategy update since early 2013, but few expect a major shift like the split-up recently proposed by Daniel Loeb's Third Point hedge fund.
Jim Tully's hours-long walks to and from work in the Pocono Mountains, where he has been repeatedly stopped by police in a case of mistaken identity in the manhunt for a Pennsylvania cop killer, may be coming to an end.
Amazon.com Inc's (AMZN.O) once fairy-tale ride on Wall Street has hit its most jarring bump yet. The company that for years enthralled investors with improbable growth and earned one of the technology sector's highest valuations drew widespread ire after a spectacular results letdown on Thursday.
Google Inc Chief Executive Officer Larry Page has put Sundar Pichai, one of his key lieutenants, in charge of the Internet company's products.
Slumping energy shares drove the recent U.S. stock market selloff more than any other major group, so investors are turning to next week's slate of earnings to see if the sector can pull itself out of the pit.
Ford Motor Co's (F.N) new chief executive, Mark Fields, is giving the automaker's long-moribund Lincoln brand what his predecessor Alan Mulally never could: a little love and a lot of cash.